Published in Neurobiol Dis on March 01, 2005
Short-term exposure of multipotent stromal cells to low oxygen increases their expression of CX3CR1 and CXCR4 and their engraftment in vivo. PLoS One (2007) 2.06
Optimizing the success of cell transplantation therapy for stroke. Neurobiol Dis (2009) 1.61
Biodistribution of neural stem cells after intravascular therapy for hypoxic-ischemia. Stroke (2010) 1.37
Neurorestorative treatment of stroke: cell and pharmacological approaches. NeuroRx (2006) 1.37
Effects of intravenous administration of allogenic bone marrow- and adipose tissue-derived mesenchymal stem cells on functional recovery and brain repair markers in experimental ischemic stroke. Stem Cell Res Ther (2013) 1.24
Benefits of hypoxic culture on bone marrow multipotent stromal cells. Am J Blood Res (2012) 1.11
Human microglia transplanted in rat focal ischemia brain induce neuroprotection and behavioral improvement. PLoS One (2010) 1.07
The CCR2/CCL2 interaction mediates the transendothelial recruitment of intravascularly delivered neural stem cells to the ischemic brain. Stroke (2011) 1.05
Gene therapies that restore dystrophin expression for the treatment of Duchenne muscular dystrophy. Hum Genet (2016) 1.04
Autologous intravenous bone marrow mononuclear cell therapy for patients with subacute ischaemic stroke: a pilot study. Indian J Med Res (2012) 1.00
Neural precursor cells in the ischemic brain - integration, cellular crosstalk, and consequences for stroke recovery. Front Cell Neurosci (2014) 0.98
Investigational therapies for ischemic stroke: neuroprotection and neurorecovery. Neurotherapeutics (2011) 0.98
Stem cell therapy for acute cerebral injury: what do we know and what will the future bring? Curr Opin Neurol (2013) 0.91
Role of neural precursor cells in promoting repair following stroke. Acta Pharmacol Sin (2012) 0.91
Trophic factors and cell therapy to stimulate brain repair after ischaemic stroke. J Cell Mol Med (2012) 0.90
Endovascular transplantation of stem cells to the injured rat CNS. Neuroradiology (2009) 0.89
The Dark Side of the Force - Constraints and Complications of Cell Therapies for Stroke. Front Neurol (2015) 0.89
Arterially perfused neurosphere-derived cells distribute outside the ischemic core in a model of transient focal ischemia and reperfusion in vitro. PLoS One (2008) 0.84
New endovascular method for transvascular exit of arteries and veins: developed in simulator, in rat and in rabbit with full clinical integration. PLoS One (2010) 0.84
Notch1 signaling modulates neuronal progenitor activity in the subventricular zone in response to aging and focal ischemia. Aging Cell (2013) 0.82
Duchenne muscular dystrophy: current cell therapies. Ther Adv Neurol Disord (2015) 0.81
Human neural stem cells promote proliferation of endogenous neural stem cells and enhance angiogenesis in ischemic rat brain. Neural Regen Res (2016) 0.79
Novel insight into stem cell trafficking in dystrophic muscles. Int J Nanomedicine (2012) 0.79
The Effect of CXCR4 Overexpression on Mesenchymal Stem Cell Transplantation in Ischemic Stroke. Cell Med (2012) 0.79
Multimodality molecular imaging of stem cells therapy for stroke. Biomed Res Int (2013) 0.78
Menstrual blood transplantation for ischemic stroke: Therapeutic mechanisms and practical issues. Interv Med Appl Sci (2012) 0.78
Bone marrow mesenchymal stem cell therapy in ischemic stroke: mechanisms of action and treatment optimization strategies. Neural Regen Res (2016) 0.77
New Concept of Neural Stem Cell Transplantation: Anti-inflammatory Role. Int J Stem Cells (2008) 0.76
Functional recovery after acute intravenous administration of human umbilical cord mesenchymal stem cells in rats with cerebral ischemia-reperfusion injury. Intractable Rare Dis Res (2015) 0.76
Stroke alters behavior of human skin-derived neural progenitors after transplantation adjacent to neurogenic area in rat brain. Stem Cell Res Ther (2017) 0.75
Current status of cell therapies in stroke. Int J Stem Cells (2009) 0.75
Electrophysiological properties of mouse cortical neuron progenitors differentiated in vitro and in vivo. Int J Clin Exp Med (2008) 0.75
Key role of 15-LO/15-HETE in angiogenesis and functional recovery in later stages of post-stroke mice. Sci Rep (2017) 0.75
G-CSF for mobilizing transplanted bone marrow stem cells in rat model of Parkinson's disease. Iran J Basic Med Sci (2016) 0.75
Combining Injectable Plasma Scaffold with Mesenchymal Stem/Stromal Cells for Repairing Infarct Cavity after Ischemic Stroke. Aging Dis (2017) 0.75
Behavioral assessment of cell transplantation after focal cerebral ischemia in rats. J Exerc Rehabil (2015) 0.75
Vascular endothelial growth factor (VEGF) stimulates neurogenesis in vitro and in vivo. Proc Natl Acad Sci U S A (2002) 5.09
VEGF-induced neuroprotection, neurogenesis, and angiogenesis after focal cerebral ischemia. J Clin Invest (2003) 4.74
Increased hippocampal neurogenesis in Alzheimer's disease. Proc Natl Acad Sci U S A (2003) 3.52
Coupling endoplasmic reticulum stress to the cell death program: role of the ER chaperone GRP78. FEBS Lett (2002) 2.71
Directed migration of neuronal precursors into the ischemic cerebral cortex and striatum. Mol Cell Neurosci (2003) 2.68
The genome of the pear (Pyrus bretschneideri Rehd.). Genome Res (2012) 2.55
Evidence for stroke-induced neurogenesis in the human brain. Proc Natl Acad Sci U S A (2006) 2.55
Reversal of Alzheimer's-like pathology and behavior in human APP transgenic mice by mutation of Asp664. Proc Natl Acad Sci U S A (2006) 2.45
Neuroglobin protects the brain from experimental stroke in vivo. Proc Natl Acad Sci U S A (2003) 2.42
Neurogenesis and aging: FGF-2 and HB-EGF restore neurogenesis in hippocampus and subventricular zone of aged mice. Aging Cell (2003) 2.27
Enhanced neurogenesis in Alzheimer's disease transgenic (PDGF-APPSw,Ind) mice. Proc Natl Acad Sci U S A (2004) 2.20
Neuroglobin-overexpressing transgenic mice are resistant to cerebral and myocardial ischemia. Proc Natl Acad Sci U S A (2006) 2.05
NOS1AP is a genetic modifier of the long-QT syndrome. Circulation (2009) 2.00
VEGF-B is dispensable for blood vessel growth but critical for their survival, and VEGF-B targeting inhibits pathological angiogenesis. Proc Natl Acad Sci U S A (2009) 1.91
Cathepsin L in secretory vesicles functions as a prohormone-processing enzyme for production of the enkephalin peptide neurotransmitter. Proc Natl Acad Sci U S A (2003) 1.83
Hypoxic induction of endoglin via mitogen-activated protein kinases in mouse brain microvascular endothelial cells. Stroke (2003) 1.70
Transgenic ablation of doublecortin-expressing cells suppresses adult neurogenesis and worsens stroke outcome in mice. Proc Natl Acad Sci U S A (2010) 1.69
Type 1 insulin-like growth factor receptor (IGF-IR) signaling inhibits apoptosis signal-regulating kinase 1 (ASK1). J Biol Chem (2003) 1.64
Stem cell factor stimulates neurogenesis in vitro and in vivo. J Clin Invest (2002) 1.63
Non-replication of association studies: "pseudo-failures" to replicate? Genet Med (2007) 1.62
Common and unique susceptibility loci in Graves and Hashimoto diseases: results of whole-genome screening in a data set of 102 multiplex families. Am J Hum Genet (2003) 1.59
Statins, autophagy and cancer metastasis. Int J Biochem Cell Biol (2012) 1.56
HLODs remain powerful tools for detection of linkage in the presence of genetic heterogeneity. Am J Hum Genet (2002) 1.51
Double bromodomain-containing gene Brd2 is essential for embryonic development in mouse. Dev Dyn (2009) 1.51
Mortality among Canadian women with cosmetic breast implants. Am J Epidemiol (2006) 1.51
Quantification of type I error probabilities for heterogeneity LOD scores. Genet Epidemiol (2002) 1.50
Palmitoylethanolamide increases after focal cerebral ischemia and potentiates microglial cell motility. J Neurosci (2003) 1.49
Patient survival and healthcare utilization costs after diagnosis of triple-negative breast cancer in a United States managed care cancer registry. Curr Med Res Opin (2012) 1.48
FGF-2 promotes neurogenesis and neuroprotection and prolongs survival in a transgenic mouse model of Huntington's disease. Proc Natl Acad Sci U S A (2005) 1.46
Caspase cleavage of members of the amyloid precursor family of proteins. J Neurochem (2002) 1.46
Pathogenic EFHC1 mutations are tolerated in healthy individuals dependent on reported ancestry. Epilepsia (2014) 1.46
Neuroglobin expression in neurogenesis. Neurosci Lett (2013) 1.42
Amino acid substitutions in the thyroglobulin gene are associated with susceptibility to human and murine autoimmune thyroid disease. Proc Natl Acad Sci U S A (2003) 1.41
A C/T single-nucleotide polymorphism in the region of the CD40 gene is associated with Graves' disease. Thyroid (2002) 1.41
Heparin-binding epidermal growth factor-like growth factor: hypoxia-inducible expression in vitro and stimulation of neurogenesis in vitro and in vivo. J Neurosci (2002) 1.40
Hemin induces neuroglobin expression in neural cells. Blood (2002) 1.40
Centrotemporal sharp wave EEG trait in rolandic epilepsy maps to Elongator Protein Complex 4 (ELP4). Eur J Hum Genet (2009) 1.37
The herbicide paraquat induces dopaminergic nigral apoptosis through sustained activation of the JNK pathway. J Biol Chem (2004) 1.37
Defective adult neurogenesis in CB1 cannabinoid receptor knockout mice. Mol Pharmacol (2004) 1.34
Centralizing the non-central chi-square: A new method to correct for population stratification in genetic case-control association studies. Genet Epidemiol (2006) 1.33
Increased severity of stroke in CB1 cannabinoid receptor knock-out mice. J Neurosci (2002) 1.33
Regulation of hypoxic neuronal death signaling by neuroglobin. FASEB J (2008) 1.33
Vascular endothelial growth factor overexpression delays neurodegeneration and prolongs survival in amyotrophic lateral sclerosis mice. J Neurosci (2007) 1.33
Neuroglobin attenuates beta-amyloid neurotoxicity in vitro and transgenic Alzheimer phenotype in vivo. Proc Natl Acad Sci U S A (2007) 1.32
Vascular endothelial growth factor stimulates neurite outgrowth from cerebral cortical neurons via Rho kinase signaling. J Neurobiol (2006) 1.31